E815
TEAS SECTION 8 & 15 RECEIVED
07/14/2026
Back to search
Official data from USPTO
DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
07/14/2026
Trademark type
Combined
Nice classes
5, 44
Filing date
09/13/2019
Registration date
07/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2021
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
CARRIGTOHILL, CO. CORK, IE
Examiner
THOMAS-RIGGS, LESLIE A
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP" contained within a blue oblong shaped pill design. All instances of the color white in the mark represent background and/or transparent areas only and are not features of the mark.
Holders and representatives
Holders
G. U. (pessoa física)
G. U. (pessoa física)
Representatives
Danielle Feria Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide
Class 44
Information and advisory services relating to pharmaceuticalsdiseases and medical conditions and treatmentspharmaceutical advicemedical and pharmaceutical consultationmedical advisory servicesproviding medical informationconsultancy and advisory services; information and advisory services relating to pharmaceuticalsdiseases and medical conditions and treatmentspharmaceutical advicemedical and pharmaceutical consultationmedical advisory servicesproviding medical informationconsultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection
Publications
History of USPTO decisions and trademark events.
40 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/13/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/10/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/04/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/03/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
05/03/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2020
PUBO
PUBLISHED FOR OPPOSITION
11/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/14/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/29/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
09/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
09/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2020
ALIE
ASSIGNED TO LIE
08/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/06/2020
GNRT
NON-FINAL ACTION E-MAILED
04/06/2020
CNRT
NON-FINAL ACTION WRITTEN
04/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2019
GNRT
NON-FINAL ACTION E-MAILED
12/21/2019
CNRT
NON-FINAL ACTION WRITTEN
12/21/2019
DOCK
ASSIGNED TO EXAMINER
12/14/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2019
NWAP
NEW APPLICATION ENTERED
09/17/2019
Continuous trademark protection
Get notified about every new filing that threatens DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.